Superbugs surface in daily life: a silent pandemic from rivers to skin, challenging global health
Once confined largely to hospital environments, bacteria highly resistant to most antimicrobial drugs are now increasingly permeating everyday life, posing a significant public health challenge. Recent groundbreaking studies supported by Fapesp in 2025 highlight the alarming spread of these “superbugs” across various settings, from urban rivers to household pets and even common skin infections.
One pivotal investigation unveiled a highly antibiotic-resistant clone within the Tietê River in São Paulo, Brazil. This discovery, detailed in the journal *One Health*, underscores how extensively these resilient microorganisms have penetrated natural ecosystems, complicating efforts to control their spread.
Simultaneously, another concerning variant of a different bacterium, exceptionally lethal, was identified in a domestic dog that tragically died after an extended hospitalization. These findings, published in *Veterinary Microbiology*, demonstrate the expanding reach of superbacteria beyond human clinical settings, affecting animals and potentially reflecting broader environmental contamination.
Rising threat in urban waterways
The specific bacterium isolated from the Tietê River, *Acinetobacter baumannii*, exhibited not only genes for antibacterial resistance but also heightened virulence. Researchers note this dual attribute is becoming increasingly common, presenting a more complex challenge for treatment. Historically, experts often encountered bacteria that were either resistant or virulent; the simultaneous presence of both traits in new strains significantly complicates infection management.
Collected by Cetesb, São Paulo’s environmental agency, as part of the OneBR project’s monitoring efforts, this clone demonstrated resistance to carbapenems—a critical class of antibiotics. The World Health Organization (WHO) has categorized such carbapenem-resistant lineages, found globally, as a critical priority pathogen, signaling an urgent need for intervention.
Canine companion succumbed to resistant strain
The pervasive presence of superbugs in the environment is a plausible route for the contamination of a two-year-old German Spitz dog. The animal contracted a resistant strain of *Klebsiella pneumoniae*, known as ST323, after ingesting something accidentally, leading to severe hemorrhagic gastroenteritis.
Despite days of hospitalization and various antimicrobial treatments, including ampicillin/sulbactam and metronidazole, the dog’s condition worsened, progressing to severe pancreatitis and diffuse peritonitis before succumbing to the infection. It is notable that the animal was not treated with carbapenems, yet the bacterium proved resistant to this class, illustrating the intricate mechanisms of resistance development.
Researchers suggest that human-to-animal transmission might be a factor, with pet owners potentially bringing resistant bacteria home from hospital stays. Given pets’ grooming habits, these bacteria could then be transferred from their mouths to other systems, such as the urinary tract, where multi-resistant urinary tract infections are increasingly observed in domestic animals.
A common skin bacterium turns deadly
In a particularly alarming instance from 2023, a common human skin bacterium, *Staphylococcus aureus*, mutated into a variant that caused a fatal systemic infection in an 18-year-old woman. She had sought medical attention for a persistent stiff neck and a seemingly harmless, painless facial pimple just over 24 hours prior to her death.
Genomic sequencing and resistance tests, with results published in *The Lancet Microbe* in November 2025, identified the variant as methicillin-resistant. This type of resistance was responsible for an estimated 23,400 deaths across the Americas in 2019. The specific lineage, USA300-NAE, is notorious for causing skin and soft tissue infections, precisely matching the young woman’s initial symptoms.
For community-acquired infections, medical responses must become more cautious, actively considering the possibility of multi-resistant bacteria. Accurate laboratory diagnostics, including antibiotic susceptibility testing, are crucial and should ideally precede prescription. The indiscriminate use of antibiotics is a primary driver of resistance, highlighting the need for precise and informed treatment decisions.
The urgent call for a one health approach
These recent cases underscore the critical need to address antimicrobial resistance through a “One Health” lens, integrating human, animal, and environmental health strategies. Experts emphasize that the judicious use of antimicrobials is paramount, alongside the implementation of robust public education policies and faster, more accurate diagnostic capabilities across healthcare systems.
The coordinator of these studies, Nilton Lincopan, a professor at the University of São Paulo’s Institute of Biomedical Sciences and researcher at the Aries (São Paulo Institute for Antimicrobial Resistance), stresses that these incidents are not isolated. He highlights the urgency for a unified approach to surveillance, diagnosis, management, and control of antimicrobial resistance, advocating for initiatives like the OneBR genomic database.
Advancing diagnostics and public policy
Molecular diagnostic laboratories, currently concentrated in universities and larger private hospitals, are indispensable for identifying critical priority pathogens and guiding appropriate treatments. They also play a vital role in implementing preventive epidemiological control measures. Expanding partnerships with public hospitals to increase testing access and affordability is a pressing public health imperative.
The current molecular diagnostic methods, including genomic sequencing and data analysis, are vital for identifying international clones and high-risk lineages of bacteria. Such advanced tools are crucial for understanding the evolving landscape of antimicrobial resistance and informing public health interventions effectively.
The potential for these pathogens to enter natural environments through hospital effluents is a significant concern. Research suggests that some strains are resistant even to standard wastewater treatments and common cleaning products. Developing new effluent treatments is as crucial as developing new antibiotics to prevent the spread of these pathogens into nature, a challenge faced by urban rivers worldwide.
Global scope of antimicrobial resistance
Antimicrobial resistance is recognized by the WHO as one of the most significant threats to global public health and development. Estimates from 2019, the last major global assessment, indicate that multi-resistant bacteria were directly responsible for 1.27 million deaths and contributed to an additional 4.95 million fatalities worldwide. This data underscores the profound and escalating impact of superbugs on global mortality and morbidity.






